Skip to main content

Jessica
Schue
,
PhD

Assistant Scientist

Departmental Affiliations

Primary
Division
Global Disease Epidemiology and Control

Contact Info

Research Interests

Infectious disease epidemiology, malaria, HIV, infectious disease surveillance, maternal vaccines, vaccine development, randomized control trials, vaccine preventable diseases

Experiences & Accomplishments
Education
PhD
Johns Hopkins Bloomberg School of Public Health
2022
MSPH
Johns Hopkins Bloomberg School of Public Health,
2016
BS
University of Minnesota Duluth
2006
Overview

Jessica L Schue, PhD, is an Assistant Scientist at the Johns Hopkins Bloomberg School of Public Health, in the Department of International Health. Dr. Schue is an infectious disease epidemiologist with special interest in health inequities and disadvantaged populations. Her previous experiences have focused on infectious diseases from a multidisciplinary perspective including microbiology, immunology, epidemiology, clinical trials, statistics, and global health. Research and practice experience have spanned several different topics including routine immunization, maternal immunization, vaccine development, HIV/AIDS, malaria, and cholera.

Honors & Awards
  • The Johns Hopkins Malaria Research Institute pre-doctoral fellowship (2019)
  • Johns Hopkins Center for Global Health Field Research Award (2018)
  • Delta Omega Honorary Society in Public Health, Alpha Chapter (2016)
  • Program in Applied Vaccine Experiences Scholar, The Johns Hopkins Vaccine Initiative (2015)
Select Publications

Select Recent Publications

  • Limaye RJ, Singh P, Fesshaye B, Lee C, Schue J, Karron RA. “Why has this new vaccine come and for what reasons?” key antecedents and questions for acceptance of a future maternal GBS vaccine: Perspectives of pregnant women, lactating women, and community members in Kenya. Human Vaccines & Immunotherapeutics. 2024; 20(1). 

  • Nyenswah TG, Skrip L, Stone M, Schue JL, Peters DH, Brieger WR. Documenting the development, adoption and pre-ebola implementation of Liberia’s integrated disease surveillance and response (IDSR) strategy. BMC Public Health. 2023 Oct 25. 23, 2093. 

  • Sutcliffe CG, Moyo N, Hamahuwa M, Mutanga JN, van Dijk JH, Hamangaba F, Schue JL, Thuma PE, Moss WJ., The Evolving Pediatric HIV Epidemic in Rural Southern Zambia: The Beneficial Impact of Advances in Prevention and Treatment at a District Hospital From 2007 to 2019. Pediatric Infectious Disease Journal. 2023 Mar 16;42(6):489-495. 

  • Ippolito MM, Gebhardt ME, Ferriss E, Schue JL, Kobayashi T, Chaponda M, Kabuya JB, Muleba M, Mburu M, Matoba J, Musonda M, Katowa B, Lubinda M, Hamapumbu H, Simubali L, Mudenda T, Wesolowski A, Shields TM, Hackman A, Shiff C, Coetzee M, Koekemoer LL, Munyati S, Gwanzura L, Mutambu S, Stevenson JC, Thuma PE, Norris DE, Bailey JA, Juliano JJ, Chongwe G, Mulenga M, Simulundu E, Mharakurwa S, Agre PC, Moss WJ. “Scientific Findings of the Southern and Central Africa International Center of Excellence for Malaria Research: Ten Years of Malaria Control Impact Assessments in Hypo-, Meso-, and Holoendemic Transmission Zones in Zambia and Zimbabwe.” Am J Trop Med Hyg. 2022 Oct 11;107(4_Suppl):55-67. 

  • Schue JLvan Dijk JH, Hamangaba F, Thuma PE, Moss WJ, and Sutcliffe CG. (2021) “Treatment outcomes among infants and children living with HIV in rural Zambia, 2008-2018: a cohort study.”  BMC Pediatr 21, 315 

Projects
Maternal Immunization Readiness Initiative
Family Connections cluster RCT